FBXW2 and gastric cancer: Gain- and loss-of-function experiments uncover that FBXW2 overexpression suppresses proliferation, stemness, migratory capacity, and invasive potential in human GC cells and tumor xenografts, while silencing of FBXW2 yield the opposite results.